Diabetes

mAb glucagon receptor blocker suitable for further development

(HealthDay)—The glucagon receptor blocker REGN1193, a fully human monoclonal antibody, seems safe and tolerable enough for further development, according to a study published online July 28 in Diabetes, Obesity and Metabolism.

Diabetes

Similar defects ID'd for T2DM, chronic pancreatitis and diabetes

(HealthDay)—Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia, according to a study published online ...

Diabetes

For diabetics, nasal powder fixed severe low blood sugar

(HealthDay)—For many people with diabetes, low blood sugar levels are a serious health risk, but researchers report that a new nasal powder quickly reverses the effects of this dangerous condition.

Diabetes

Glucagon receptor antagonist ups blood pressure in T2DM

(HealthDay)—For patients with type 2 diabetes, once-daily treatment with the glucagon receptor antagonist LY2409021 is associated with increases in ambulatory blood pressure (BP), according to a study published online Feb. ...

Medical research

Smart drug clears fat from liver and blood

Scientists of Helmholtz Zentrum München and Technische Universität München have developed a 'smart' drug that safely clears the liver of fat and prevents blood vessels from clogging up. Similar to a trojan horse, the drug ...

page 4 from 7